2026 ASCO Breast Cancer Highlights: BWEL - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

2026 ASCO Breast Cancer Highlights: BWEL

Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD discuss new research from the Breast Cancer Weight Loss (BWEL) trial, as well as recommendations for lifestyle, diet and GLP1 agonists.

  • October 15, 2026

Share

  • 1

    Harold Burstein, MD, PhD, and Jennifer A. Ligibel, MD, discuss new research from the Breast Cancer Weight Loss trial.

  • 2

    The trial is identified as the Breast Cancer Weight Loss (BWEL) trial.

  • 3

    The discussion includes recommendations for lifestyle.

  • 4

    The discussion includes recommendations for diet.

  • 5

    The discussion includes recommendations for GLP-1 agonists.

Original Source(s)

2026 ASCO Breast Cancer Highlights: BWEL

  • October 15, 2026

Related Content

Physician- and Practice-Level Variation in Clinical Trial Participation Among Patients With Advanced Cancer

A Glimpse into the Future of Analytical Instrument Design?

Michael John Fanous’s portable scanner uses AI to reconstruct images blurred by continuous high-speed acquisition

Resection zone prediction for parenchyma-sparing hepatectomy planning: a comparative study of three modeling paradigms